Cargando…

Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study

PURPOSE: This study aimed to compare progression-free survival (PFS), overall survival (OS), and cancer-specific survival (CSS) in Heng intermediate-risk patients with metastatic renal cell carcinoma (mRCC) treated with first-line immunotherapy (IT) or targeted therapy (TT). MATERIALS AND METHODS: F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Han, Lee, Dong-Eun, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052413/ https://www.ncbi.nlm.nih.gov/pubmed/32158965 http://dx.doi.org/10.4111/icu.2020.61.2.146

Ejemplares similares

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy
por: Kim, Sung Han, et al.
Publicado: (2019)

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching
por: Kim, Sung Han, et al.
Publicado: (2018)

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2017)

Analysis of Changes in the Total Lymphocyte and Eosinophil Count during Immunotherapy for Metastatic Renal Cell Carcinoma: Correlation with Response and Survival
por: Jeong, In Gab, et al.
Publicado: (2007)

Honoring a legend: Celebrating the life and legacy of Professor Heng Li
por: Guo, Hui-Jun, et al.
Publicado: (2023)

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis
por: Kim, Sung Han, et al.
Publicado: (2019)

Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison
por: Kim, Sung Han, et al.
Publicado: (2017)

Experimental Verification of CAPN1 and CAST Gene Polymorphisms in Different Generations of Da-Heng Broilers
por: Zhou, Yu-Guang, et al.
Publicado: (2017)

Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis
por: Kim, Sung Han, et al.
Publicado: (2018)

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Effects of Slaughter Age on Muscle Characteristics and Meat Quality Traits of Da-Heng Meat Type Birds
por: Li, Jingjing, et al.
Publicado: (2019)

Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study
por: Kim, Sung Han, et al.
Publicado: (2016)

Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy
por: Kim, Sung Han, et al.
Publicado: (2017)

Identification of the Powdery Mildew Resistance in Chinese Wheat Cultivar Heng 4568 and its Evaluation in Marker-Assisted Selection
por: Gao, Huiming, et al.
Publicado: (2022)

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021)

Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma
por: Kim, Sung Han, et al.
Publicado: (2017)

Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors
por: Zhao, Xiaoliang, et al.
Publicado: (2017)

A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma
por: Kim, Moon Jin, et al.
Publicado: (2016)

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Performance of Co-Housed Neon Tetras (Paracheirodon innesi) and Glowlight Rasboras (Trigonostigma hengeli) Fed Commercial Flakes and Lyophilized Natural Food
por: Kasprzak, Robert, et al.
Publicado: (2021)

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
por: Kim, Myung Soo, et al.
Publicado: (2018)

Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors
por: Zhao, Xiaoliang, et al.
Publicado: (2019)

Pazopanib in patients with metastatic renal cell carcinoma: a single-center, real-world, retrospective Chinese study
por: Chen, Jianhui, et al.
Publicado: (2021)

A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma
por: Byeon, Seonggyu, et al.
Publicado: (2016)

Clear cell papillary renal cell carcinoma: A case report and review of the literature
por: Kim, Sung Han, et al.
Publicado: (2018)

Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma
por: Kim, Jee Hung, et al.
Publicado: (2018)

Real world treatment sequences and outcomes for metastatic renal cell carcinoma
por: Lai, Gu-Shun, et al.
Publicado: (2023)

Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021)

Schlechte Prognose bei Schlaganfall
por: Diener, Hans-Christoph
Publicado: (2020)

Hohes Risiko, schlechte Prognose
por: Diener, Hans-Christoph
Publicado: (2021)

Schlechtere Prognose nach Schlaganfall
por: Diener, Hans-Christoph
Publicado: (2022)

A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2022)

The Worsening Renal Perfusion Index Predicts the Prognoses of Heart Failure Patients Treated with Sacubitril/Valsartan
por: Hsu, Wan-Tseng, et al.
Publicado: (2023)

Comparison of the prognoses of laryngeal preneoplastic lesions based on Ljubljana and World Health Organization classifications
por: DOĞAN, Ersoy, et al.
Publicado: (2022)

Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Liao, Limin, et al.
Publicado: (2022)

A Real-World, Population-Based Retrospective Analysis of Therapeutic Survival for Recurrent Localized Renal Cell Carcinoma After Nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
por: Kumar, Karnam Ashok, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aiqopjboaufjritm2jslcchc11